The FDA wants to pull its approval of a drug. It’s not so easy.
Source:
arsTechnica
October 31, 2026 · 04:02
From the publisher
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
About the source
Ars Technica
Ars Technica is a website covering news and opinions in technology, science, politics, and society, created by Ken Fisher and Jon Stokes in 1998. It publishes news, reviews, and guides on issues such as computer hardware and software, science, technology policy, and video games.
Wikidata Q584152
Wikidata ↗
The original article opens on the publisher's website.
More from General
View topic →Automatic 401(k) rollovers reduce cash-outs, research finds — but few accounts reach new employer plans
cnbc
Oct 31, 2026 · 06:30
In the wake of Weil, a legal recruiter's advice for surviving a company wind-down
cnbc
Oct 31, 2026 · 06:07
Crypto industry pours more than $200 million into 2026 midterms to pressure Congress on favorable rules
cnbc
Oct 31, 2026 · 06:04
18 years in, what has Bitcoin truly done?
coinDesk
Oct 31, 2026 · 06:00
How to start an art collection on any budget
cnbc
Oct 31, 2026 · 05:58